Phosphorylation of p38 mitogen-activated protein kinase downstream of bax-caspase-3 pathway leads to cell death induced by high D-glucose in human endothelial cells

Diabetes

Volumn 50, Issue 6, 2001, Pages 1472-1481

  Nakagami, Hironori ^a   Morishita, Ryuichi ^a   Yamamoto, Kei ^a   Yoshimura, Shin Ichi ^b   Taniyama, Yoshiaki ^a   Aoki, Motokuni ^a   Matsubara, Hiroaki ^c   Kim, Shokei ^d   Kaneda, Yasufumi ^a   Ogihara, Toshio ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b GIFU UNIVERSITY   (Japan)

^c KANSAI MEDICAL UNIVERSITY   (Japan)

^d Osaka City Medical Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CASPASE 3; CASPASE INHIBITOR; GLUCOSE; LEVO GLUCOSE; MANNITOL; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; PROTEIN BAX;

AORTA; APOPTOSIS; ARTICLE; CELL COUNT; CELL DEATH; CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT;

EID: 0034993799     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.6.1472     Document Type: Article

References (56)

1. Hypertension, the endothelial cell, and the vascular complications of diabetes mellitus
2. Diabetes and glucose tolerance as risk factors for cardiovascular disease: The Framingham study
3. Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C
4. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
5. Expression of vascular endothelial growth factor in response to high glucose in rat mesangial cells
6. Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes
7. Potential role of endothelium-specific growth factor, hepatocyte growth factor, on endothelial damage in diabetes mellitus
8. Glucose toxicity for human endothelial cells in culture: Delayed replication, disturbed cell cycle, and accelerated death
9. Role of hepatocyte growth factor in endothelial regulation: Prevention of high D-glucose-induced endothelial cell death by prostaglandins and phosphodiesterase type 3 inhibitor
10. Programmed cell death in animal development
11. Is programmed cell death required for neural tube closure?
12. High-glucose-triggered apoptosis in cultured endothelial cells
13. Mitochondria and apoptosis
14. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c
15. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis
16. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked
17. Requirement for ceramido-initiated SAPK/JNK signalling in stress-induced apoptosis
18. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
19. Daax, a novel Fas-binding protein that activates JNK and apoptosis
20. Fas activation of the p38 mitogen-activated protein kinase signalling pathway requires ICE/CED-3 family proteases
21. 2-terminal kinase and induction of apoptosis after detachment of epithelial cells
22. Signal transduction pathways regulated by mitogen-activated/extracellular response kinase kinase kinase induce cell death
23. Three distinct signalling responses by murine fibroblasts to genotoxic stress
24. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kB activation prevents cell death
25. Ordering the cell death pathway: Differential effects of Bcl-2, an interleukin-1-converting enzyme family protease inhibitor, and other survival agents of JNK activation in serum/nerve growth factor-deprived PC12 cells
26. Fibroblast growth factor-2 suppression of tumor necrosis factor α-mediated apoptosis requires Ras and the activation of mitogen-activated protein kinase
27. Intercellular adhesion molecule-1 gene expression in human endothelial cells
28. Culture of quiescent arterial smooth muscle cells in a defined serum-free medium
29. A new sulfonated tetrazolium salt that produces a highly water-soluble formazan dye
30. Induction of apoptosis as well as necrosis by hypoxia and predominant prevention of apoptosis by Bcl-2 and Bcl-xL
31. Inhibition of p53 tumor suppressor gene resulted in growth of human aortic vascular smooth muscle cells (VSMC): Potential role of p53 in regulation of VSMC growth
32. Fas antigen and bcl-2 expression on lymphocytes cultured with cytomegalovirus and varicella-zoster virus antigen
33. Bcl-2 expression prevents activation of the ICE protease cascade
34. The stress inducer arsenite activates mitogen-activated protein kinases extracellular signal-regulated kinases 1 and 2 via a MAPK kinase 6/p38-dependent pathway
35. Bcl-2 and the regulation of programmed cell death
36. Interactions among members of the bcl-2 protein family analyzed with a yeast two-hybrid system
37. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis
38. Cytosol-to-membrane redistribution of bax and bcl-xL during apoptosis
39. MEKKs, GCKs, MLKs, PAKs, TAKs, and tpls: Upstream regulators of the c-Jun amino-terminal kinases?
40. Sounding the alarm: Protein kinase cascades activated by stress and inflammation
41. The regulation of anoikis: MEKK-1 activation requires cleavage by caspases
42. MEK kinase 1, a substrate for DEVD-directed caspases, is involved in genotoxin-induced apoptosis
43. 2-terminal kinase activation in response to changes in the microtubule cytoskeleton
44. The emerging concept of vascular remodeling
45. Mechanisms of vascular remodeling in hypertension: Role of autocrine-paracrine vasoactive factors
46. Exposure to elevated D-glucose concentrations modulates vascular endothelial cell vasodilatory response
47. Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro
48. Hyperglycemia induced apoptosis in pre-implantation embryos through cell death effector pathways
49. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death
50. Investigation of the subcellular distribution of the bcl-2 oncoprotein: Residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes
51. Differential role of the JNK and p38 MAPK pathway in c-Myc- and s-Myc-mediated apoptosis
52. The activation of p38 and apoptosis by the inhibition of ERK is antagonized by the phosphoinositide 3-kinase/Akt pathway
53. Molecular cloning of mitogen-activated protein/ERK kinase kinases (MEKK) 2 and 3: Regulation of sequential phosphorylation pathways involving mitogen-activated protein kinase and c-jun kinase
54. A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf
55. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms
56. Induction of cyclooxygenase-2 by the activated MEKK1-SEK1/MKK4-p38 mitogen-activated protein kinase pathway